Donderdag cijfers VS o.a. Bsquare en CafePress
8 november 2016
Op donderdag 10 november presenteren onder andere deze Amerikaanse bedrijven hun kwartaal- en of jaarcijfers:
Accelerize Adamas Pharmaceuticals Affinion Groups Air Industries Group Aldeyra Therapeutics Amedica American DG Energy American Shared Hospital Services ARC Group Worldwide ARCA Biopharma Ardelyx Arrhythmia Research Technology Atossa Genetics Auris Medical AG Avalons Aviat Networks Bellerophon Therapeutics BioLife Solutions Biostage Birner Dental Management Services Blue Buffalo Pet Products Blue Calypso BlueLinxs Brooks Automation Bsquare CafePress Cambium Learning Group Canterbury Park Capricor Therapeutics Cardconnect Care Capital Properties Cartesian Catabasis Pharmaceuticals CCOM Group Cellectar Biosciences Central Federal Chembio Diagnostics Chromadex Clearfield ClearSignmbustion Collegium Pharmaceutical ContraFect Corium International Cosi Cotivitis Crown Crafts Cyanotech Cyclacel Pharmaceuticals CymaBay Therapeutics Darling Ingredients Deep Down Derma Sciences Determine DGSEmpanies Dyadic International e.Digital Earthstone Energy Edgewell Personal Care EnerSys Enservco EnSync EQUUS Total Return Espey MFG and Electronics Esterline Technologies Etrion SA Fennec Pharmaceuticals First Acceptance First United FitLife Brands Flowers Foods Forbes Energy Services Gaming Partners International Geovax Labs Global Medical REIT GlycoMimetics Goldfield Griffon Guided Therapeutics Histogenics Hooper Holmes hopTo Ideal Power Identiv ImmuCell Immune Pharmaceuticals ImmunoCellular Therapeutics Imprimis Pharmaceuticals InfuSystems Intellicheck Mobilisa InterCloud Systems Interleukin Genetics Interpace Diagnostics GroupSamengesteld door Analist redactie i.c.m. Citigate First Financial .
Analist.nl Nieuwsdienst: +31 084-0032-842 redactie@analist.nl
Copyright Analist.nl B.V. All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.